Reducing the risk of unsafe injections in immunization programmes: financial and operational implications of various injection technologies.

The unsafe use and disposal of injection equipment continues to put patients, health care workers, and the general community at risk of infections such as hepatitis B virus and human immunodeficiency virus. Although the potential for unsafe injection practices varies substantially with the type of equipment that is used, technology alone cannot totally eliminate the risk. A knowledge of the cost, practicality and, most importantly, the potential for misuse, is critical for selecting the most appropriate injection equipment for each immunization setting. Four types of injection equipment are currently available for administering vaccines: sterilizable needles and syringes; standard disposable needles and syringes; autodestruct needles and syringes; and jet injectors. In general, the cost per injection is lowest with sterilizable equipment and highest with autodestruct. However, only autodestruct syringes virtually eliminate the risk of unsafe injection practices. Owing to differences in cost and programme factors, in some settings it may be appropriate to use a combination of equipment. For example, autodestruct syringes may be used in areas where it is difficult to ensure adequate supervision, while in medium-sized, fixed-site clinics with safe injection practices, sterilizable equipment will be the most cost-effective.

[1]  J. Warren,et al.  Large-scale administration of vaccines by means of an automatic jet injection syringe. , 1955, Journal of the American Medical Association.

[2]  H. Wyatt The popularity of injections in the Third World: origins and consequences for poliomyelitis. , 1984, Social science & medicine.

[3]  A. V. van Loon,et al.  Virus transmission by subcutaneous jet injection. , 1985, Journal of medical microbiology.

[4]  T. Quinn,et al.  RISK FACTORS FOR HUMAN IMMUNODEFICIENCY VIRUS SEROPOSITIVITY AMONG CHILDREN 1-24 MONTHS OLD IN KINSHASA, ZAIRE , 1986, The Lancet.

[5]  L. Gürtler,et al.  RISK OF VIRUS TRANSMISSION BY JET INJECTION , 1988, The Lancet.

[6]  C. Lafaix,et al.  Incidence of intramuscular injections in rural dispensaries in developing countries. , 1989, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[7]  Guidelines for prevention of transmission of human immunodeficiency virus and hepatitis B virus to health-care and public-safety workers. , 1989, MMWR supplements.

[8]  T. S. Jones,et al.  Prevalence of HIV infection among intravenous drug users in the United States. , 1989, JAMA.

[9]  R. Soeters,et al.  Hazards of Injectable Therapy , 1989, Tropical doctor.

[10]  M. Alter,et al.  An outbreak of hepatitis B associated with jet injections in a weight reduction clinic. , 1990, Archives of internal medicine.

[11]  D. Heymann,et al.  Transmission of HIV, hepatitis B virus, and other bloodborne pathogens in health care settings: a review of risk factors and guidelines for prevention. World Health Organization. , 1991, Bulletin of the World Health Organization.

[12]  P. Hartsock,et al.  Self-destructing (non-reusable) syringes , 1991, The Lancet.

[13]  Expanded programme on immunization. Global Advisory Group--Part I. , 1992, Releve epidemiologique hebdomadaire.

[14]  A. Anan India: Unhealthy immunisation programme , 1993, The Lancet.

[15]  H. Gayle,et al.  Risk factors for HIV infection among abandoned Romanian children , 1993, AIDS.

[16]  J. Heptonstall,et al.  Hepatitis B outbreak in a drug trials unit: investigation and recommendations. , 1994, Communicable disease report. CDR review.

[17]  P. Mortimer A lurking endemic , 1994, The Lancet.

[18]  R. Steinglass,et al.  Safety, effectiveness and ease of use of a non-reusable syringe in a developing country immunization programme. , 1995, Bulletin of the World Health Organization.